Skip to main content
. Author manuscript; available in PMC: 2020 Sep 11.
Published in final edited form as: Pediatr Res. 2020 Jan 11;88(3):459–465. doi: 10.1038/s41390-020-0756-2

Table 7.

Summary of significant sex differences in DXA, circulating biomarkers, and neuromotor assessment

DXA LBM: Females lower at EOS, p = 0.0025
BMD: Females lower at EOS, p = 0.0123
Circulating biomarkers IGF-1: Females higher at EOS, p = 0.027